Medy-Tox Inc.
Biopharmaceutical firm developing botulinum toxins, HA fillers, and dermocosmetics.
086900 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086900008
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청원군 오창읍 각리1길 78 (주)메디톡스, 청원군
- Sector:
- Manufacturing
Description
Medy-Tox Inc. is a biopharmaceutical company focused on the research, development, and commercialization of biologic products. Its primary offerings are centered on botulinum toxin type A (BTX-A) formulations, including Neuronox®, INNOTOX®, Coretox®, and NEWLUX®, which are used for both aesthetic and therapeutic applications. The company is noted for developing the world's first liquid-injectable botulinum toxin. In addition to its toxin portfolio, Medy-Tox manufactures and markets a line of hyaluronic acid (HA) dermal fillers, such as Neuramis®, Atiere, and Potenfill. The company's product range also extends to dermocosmetics under the NEURADERM brand.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-11 00:00 |
[기재정정]연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 19.8 KB | ||
| 2024-10-21 00:00 |
자기주식처분결과보고서
|
Korean | 16.7 KB | ||
| 2024-10-21 00:00 |
자기주식취득결과보고서
|
Korean | 27.1 KB | ||
| 2024-10-16 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 65.8 KB | ||
| 2024-10-07 00:00 |
현금ㆍ현물배당결정 (분기배당)
|
Korean | 12.1 KB | ||
| 2024-10-02 00:00 |
투자판단관련주요경영사항 (제조판매중지명령 및 품목허가취소등 취소 소송 상고의 건)
|
Korean | 10.8 KB | ||
| 2024-09-30 00:00 |
주요사항보고서(자기주식취득결정)
|
Korean | 32.8 KB | ||
| 2024-09-30 00:00 |
[기재정정]주요사항보고서(자기주식취득결정)
|
Korean | 40.4 KB | ||
| 2024-09-27 00:00 |
타법인주식및출자증권처분결정
|
Korean | 10.0 KB | ||
| 2024-09-13 00:00 |
중간(분기)배당을위한주주명부폐쇄(기준일)결정
|
Korean | 5.4 KB | ||
| 2024-09-11 00:00 |
[첨부추가]투자판단관련주요경영사항 (제조판매중지명령 및 품목허가취소등 취소 소송 항소심 판결의 건)
|
Korean | 10.7 KB | ||
| 2024-08-19 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.7 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.5 MB | ||
| 2024-08-13 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2024-08-09 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.5 KB |
Automate Your Workflow. Get a real-time feed of all Medy-Tox Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medy-Tox Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medy-Tox Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
